Chimeric papillomavirus virus-like particles elicit antitumor immunity against the E7 oncoprotein in an HPV16 tumor model. - Wikidata - wikimedia - TriplyDB

Chimeric papillomavirus virus-like particles elicit antitumor immunity against the E7 oncoprotein in an HPV16 tumor model.

Chimeric papillomavirus virus-like particles elicit antitumor immunity against the E7 oncoprotein in an HPV16 tumor model.

http://www.wikidata.org/entity/Q35891225

about

Immunization with hepatitis C virus-like particles results in control of hepatitis C virus infection in chimpanzees Immunostimulatory Activity of the Cytokine-Based Biologic, IRX-2, on Human Papillomavirus-Exposed Langerhans Cells.Attenuated Recombinant Influenza A Virus Expressing HPV16 E6 and E7 as a Novel Therapeutic Vaccine Approach Generation of hepatitis C virus-like particles by use of a recombinant vesicular stomatitis virus vector Immunization with hepatitis C virus-like particles protects mice from recombinant hepatitis C virus-vaccinia infection.Antigen-specific immunotherapy of cervical and ovarian cancer Further Stimulation of Cellular Immune Responses through Association of HPV-16 E6, E7 and L1 Genes in order to produce more Effective Therapeutic DNA Vaccines in Cervical Cancer Model An enhanced heterologous virus-like particle for human papillomavirus type 16 tumour immunotherapy.Potential anti-HPV and related cancer agents from marine resources: an overview.Induction of CD8 T cells by vaccination with recombinant adenovirus expressing human papillomavirus type 16 E5 gene reduces tumor growth CD4+ and CD8+ T cells can act separately in tumour rejection after immunization with murine pneumotropic virus chimeric Her2/neu virus-like particles Intranasal delivery of recombinant parvovirus-like particles elicits cytotoxic T-cell and neutralizing antibody responses.Live attenuated Salmonella: a paradigm of mucosal vaccines.Papillomavirus capsid mutation to escape dendritic cell-dependent innate immunity in cervical cancer.Recombinant adeno-associated virus expressing human papillomavirus type 16 E7 peptide DNA fused with heat shock protein DNA as a potential vaccine for cervical cancer.Alternative pathways for processing exogenous and endogenous antigens that can generate peptides for MHC class I-restricted presentation.Papillomavirus pseudovirus: a novel vaccine to induce mucosal and systemic cytotoxic T-lymphocyte responses.Therapeutic HPV DNA vaccines.Murine polyomavirus virus-like particles carrying full-length human PSA protect BALB/c mice from outgrowth of a PSA expressing tumor Vaccination with HPV16 L2E6E7 fusion protein in GPI-0100 adjuvant elicits protective humoral and cell-mediated immunity.Vesicular trafficking of incoming human papillomavirus 16 to the Golgi apparatus and endoplasmic reticulum requires γ-secretase activity.The choice of resin-bound ligand affects the structure and immunogenicity of column-purified human papillomavirus type 16 virus-like particles Enhanced presentation of major histocompatibility complex class I-restricted human immunodeficiency virus type 1 (HIV-1) Gag-specific epitopes after DNA immunization with vectors coding for vesicular stomatitis virus glycoprotein-pseudotyped HIV-1 G Improvement of different vaccine delivery systems for cancer therapy.Exploiting viral properties for the rational design of modern vaccines.Interactions between papillomavirus L1 and L2 capsid proteins Adenovirus-mediated intratumoral expression of immunostimulatory proteins in combination with systemic Treg inactivation induces tumor-destructive immune responses in mouse models Vaccination with dengue virus-like particles induces humoral and cellular immune responses in mice.Chimeric human papillomavirus type 16 (HPV-16) L1 particles presenting the common neutralizing epitope for the L2 minor capsid protein of HPV-6 and HPV-16 How will HPV vaccines affect cervical cancer?Tetravalent recombinant dengue virus-like particles as potential vaccine candidates: immunological properties Cytotoxic-T-lymphocyte human papillomavirus type 16 E5 peptide with CpG-oligodeoxynucleotide can eliminate tumor growth in C57BL/6 mice.Development of HPV vaccines for HPV-associated head and neck squamous cell carcinoma.Does pretreatment seropositivity to human papillomavirus have prognostic significance for head and neck cancers?Delivering on the promise: HPV vaccines and cervical cancer.Progress on new vaccine strategies against chronic viral infections Emerging human papillomavirus vaccines.Vaccination strategies for the prevention of cervical cancer.Langerhans cells from women with cervical precancerous lesions become functionally responsive against human papillomavirus after activation with stabilized Poly-I:C Human papillomavirus-exposed Langerhans cells are activated by stabilized Poly-I:C.

P2860

Q24685256-929BB12C-AA64-40EB-BD67-8DC61FD3D6B2 Q27307719-4DA7F7CE-0867-4F5D-A78B-DA9BCC67F327 Q27316846-2B72ECCE-5FC8-445D-9BDA-62B8A4EDC45B Q27472940-CFECEC38-442A-47E1-A12B-D62966A7DD61 Q27477660-D262A806-BD81-4D21-BBE9-301490B7FE51 Q27488697-E82D8F4F-349B-4D68-BF6F-491549562A05 Q28652354-2A0F56BE-36AD-40E9-8666-515607E520ED Q31121276-1EE8BB8D-F0B8-4A1B-9CD1-E2F604A8DE86 Q33575647-60FD78A9-F612-48C7-8655-B1784DCEAC6E Q33604559-A6372C09-FCA1-49CC-ADD0-5FF4CA8B1371 Q33640368-DAA46320-AFDF-47A5-86E3-202D34EF41F6 Q33643167-65B82340-3452-4E4B-918E-04EA41A9A737 Q33784947-698A5E46-1A8F-404D-A624-E701CBCA7F4F Q33788885-B9B398E8-4469-4689-8369-28C3B516025A Q33800432-25295BD3-9891-476B-B7EC-39221F104891 Q33815400-86544587-DE72-49E4-A8B3-C24FC168198B Q33847557-C2251BF2-0DC3-4BCF-942B-92042E16BB80 Q33936427-F1B37DB5-1C5E-4C1F-BCA1-8F7FED4F6E6C Q34000082-4DC045D6-8321-472B-8745-8B98F6F764D7 Q34078674-017E4385-C2E7-4D74-B7A3-4C6E54DD5490 Q34229884-D79C3C98-49F6-4DBC-B1CE-B67F44B2C89C Q34259805-605C8BEC-BEC0-4B28-A8EF-718CD2027A09 Q34342982-4F409B03-DF24-49B8-B478-D43019967EDE Q34506877-9C0E39B0-7E1E-4AD0-959F-2322B22BCCDD Q34746490-0326021E-31AB-4D57-804F-86ECECC91D49 Q34860943-8C9A0F42-E999-4A4A-B908-6303A134FF7E Q34988018-08642A5D-34F0-46F8-A663-0F6A1ACFC614 Q35128995-A562CE51-6048-43D6-A820-BA256869E456 Q35155333-F1C02AEE-DDD2-4E4E-97E8-442DC741C8B8 Q35235035-C2E20809-0F9F-4E57-A821-CF93FABADAE9 Q35402842-73159510-AC9D-4E8B-B286-227C5278F09D Q35543857-776F4319-BD3A-4DD0-ABFE-5DC7A89C54E1 Q35552591-ECF1F887-E2D8-4CBD-AAFE-1CE71DCFD68C Q35647100-0BC919EF-C737-40D7-ACD7-38E0F153AC70 Q35697573-56333187-C6ED-4012-B636-53026C70F644 Q35864857-A3EB9567-CA68-46A2-87F3-BE52D324564A Q36066004-CB67C57D-31B1-4E77-B6FE-951CD53F97CD Q36066161-46F898FB-6F8F-4C73-A61E-67483A47DDB3 Q36315857-86A5B2A7-B604-4791-803F-58DF990E1435 Q36350381-68C54B86-4B78-484A-AB91-E568A9A58974

P2860

Chimeric papillomavirus virus-like particles elicit antitumor immunity against the E7 oncoprotein in an HPV16 tumor model.

http://www.wikidata.org/entity/Q35891225

description

1998 nî lūn-bûn

@nan

1998年の論文

@ja

1998年論文

@yue

1998年論文

@zh-hant

1998年論文

@zh-hk

1998年論文

@zh-mo

1998年論文

@zh-tw

1998年论文

@wuu

1998年论文

@zh

1998年论文

@zh-cn

name

Chimeric papillomavirus virus- ...... otein in an HPV16 tumor model.

@ast

Chimeric papillomavirus virus- ...... otein in an HPV16 tumor model.

@en

type

label

Chimeric papillomavirus virus- ...... otein in an HPV16 tumor model.

@ast

Chimeric papillomavirus virus- ...... otein in an HPV16 tumor model.

@en

prefLabel

Chimeric papillomavirus virus- ...... otein in an HPV16 tumor model.

@ast

Chimeric papillomavirus virus- ...... otein in an HPV16 tumor model.

@en

P1433

Q35891225-A62EB81B-D0A7-445D-8836-4703281230B3

P1476

Q35891225-7A06CBB7-AEB1-45C9-BA84-4B36B5A9B3EB

P2093

Q35891225-18B98626-CF2E-4D31-BDA1-9BC15A5AC6B3

Q35891225-53D62D78-E1BE-4F72-86F0-1E6BE400C632

Q35891225-8F53B0D3-619F-429D-8D36-BFC40B1BF8D7

Q35891225-9EE3F585-DB6E-4667-96C5-F3419353DAB7

Q35891225-B8AA7171-6853-4CA3-9792-DA9747F6FE94

Q35891225-C7BBA8C7-F646-4758-8732-ABB895082887

Q35891225-E60F40C4-CF5A-43CF-9172-ED2A59DB3FE1

Q35891225-F73A11FD-B00A-41AD-BB15-D9DF380DAC9C

Q35891225-FB53CADF-C8B9-425C-80D3-B5FF02C88437

P2860

Q35891225-08B29E66-C416-4492-BE69-8452F53DF3E4

Q35891225-0FA6A59F-0291-49EA-9AA4-10B20257FD28

Q35891225-1BCA84C8-5338-4913-9EB1-63CAC0CE50B6

Q35891225-2142A253-6FFA-4D18-B504-0D6CE51ACC16

Q35891225-22B682D3-0658-4138-95F2-1D1E84A31902

Q35891225-23FB947E-6024-4757-825E-E6137E26B167

Q35891225-3C0627CE-8C9E-445F-972B-B2A26702DAB8

Q35891225-4A0B2379-0B91-4972-939A-A590004C2811

Q35891225-4DF4AD47-200E-441C-8D0E-B5D2564B3343

Q35891225-5AA1840E-3C2A-4A40-9475-E70497F6D92E

P304

Q35891225-8082ACD8-EA40-4B5E-9D23-17A0241D5612

P31

Q35891225-E84309D9-CC77-4BF2-A37D-58CA648157C7

P356

Q35891225-B0BDC95F-AFC7-42D5-B2C9-6183742D87E4

P407

Q35891225-854664D3-8DD1-4035-8343-CFB06D023CD0

P433

Q35891225-40867A5F-7633-4060-9659-74BF01C4BFDB

P478

Q35891225-0F1052BC-4316-49E5-BAC2-F93F88B336C4

P577

Q35891225-E5C0DD0E-61D2-48E9-8EEF-9C7B8A6AA3AF

P5875

Q35891225-6360DE5C-06E2-4DDF-8389-2D4164675A1D

P698

Q35891225-238CE717-834A-48E1-A6A1-96A356CF041E

P932

Q35891225-561500BD-695D-4D97-9756-06811FA3E938

P356

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Chimeric papillomavirus virus- ...... otein in an HPV16 tumor model.

@en

P2093

D R Lowy

http://www.w3.org/2001/XMLSchema#string

H L Greenstone

http://www.w3.org/2001/XMLSchema#string

J D Nieland

http://www.w3.org/2001/XMLSchema#string

J T Schiller

http://www.w3.org/2001/XMLSchema#string

K E de Visser

http://www.w3.org/2001/XMLSchema#string

M L De Bruijn

http://www.w3.org/2001/XMLSchema#string

R B Roden

http://www.w3.org/2001/XMLSchema#string

R Kirnbauer

http://www.w3.org/2001/XMLSchema#string

W M Kast

http://www.w3.org/2001/XMLSchema#string

P2860

Germ-line transmission of a disrupted beta 2-microglobulin gene produced by homologous recombination in embryonic stem cells

Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice

Tolerance, danger, and the extended family

Structures of bovine and human papillomaviruses. Analysis by cryoelectron microscopy and three-dimensional image reconstruction.

Systemic immunization with papillomavirus L1 protein completely prevents the development of viral mucosal papillomas.

Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group.

Genital human papillomavirus infection

Parvovirus particles as platforms for protein presentation

Papillomavirus capsid binding and uptake by cells from different tissues and species.

Immunization with viruslike particles from cottontail rabbit papillomavirus (CRPV) can protect against experimental CRPV infection.

P304

1800-1805

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.95.4.1800

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

95

http://www.w3.org/2001/XMLSchema#string

P577

1998-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

13765970

http://www.w3.org/2001/XMLSchema#string

P698

9465097

http://www.w3.org/2001/XMLSchema#string

P932

19193

http://www.w3.org/2001/XMLSchema#string